Hematology · Acibadem Atasehir Hospital, İstanbul Prof. Dr. Gülsan Sucak
✓ Medically verified profileProf. Dr. Gülsan Sucak
Prof. Dr. Gülsan Sucak is a hematologist at Acibadem Atasehir Hospital in İstanbul, Turkey, working within the Hematology Department. She treats leukemia, lymphoma, multiple myeloma and plasma cell disorders, myeloproliferative diseases, anemia, bleeding and clotting disorders, and bone marrow diseases, and is involved in bone marrow transplantation. She consults in Turkish and English.
Accepting international patientsAbout Prof. Dr. Gülsan Sucak
Prof. Dr. Gülsan Sucak is a hematologist at Acibadem Atasehir Hospital in İstanbul, where she practices within the Hematology Department. Her clinical work covers blood cancers such as leukemia, lymphoma and multiple myeloma, bone marrow diseases, anemia, bleeding and clotting disorders, and bone marrow transplantation. She has more than 39 years of experience in medicine.
Dr. Sucak graduated from Ankara University Faculty of Medicine in 1987. She completed her training in Internal Medicine at Gazi University Faculty of Medicine in 1993 and her training in Hematology at the same faculty in 1999. Between 1993 and 1995 she worked as an Internal Medicine Specialist at Ankara Sevgi Hospital, and from 1995 to 1996 as an Internal Medicine consultant at Ankara Zekai Tahir Burak Training and Research Hospital. Her academic career at Gazi University Faculty of Medicine, Department of Hematology, progressed from Assistant Associate Professor (1999–2000) to Associate Professor (2000–2008) and Professor (2008–2015). In 2015 she joined the Bahçelievler- Medicalpark Hospital, Hematology and Bone Marrow Transplantation Unit, and in 2024 she joined Acıbadem Healthcare Services. She is a co-author of peer-reviewed publications on topics including hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria, tuberculosis infection in stem cell transplantation recipients, early transplant complications after allogeneic stem cell transplantation, COVID-19 infection in patients with acute leukemia, and hemophagocytic lymphohistiocytosis.
Clinical focus
Dr. Sucak evaluates and treats patients with malignant blood diseases, including leukemia, with a focus on acute lymphoblastic leukemia and acute myeloid leukemia, as well as lymphoma, myeloproliferative diseases, multiple myeloma and other plasma cell disorders. Her work also includes bone marrow diseases and bone marrow transplantation, an area reflected in several of her publications on hematopoietic stem cell transplantation.
In addition to blood cancers, she sees patients with non-malignant hematological conditions such as anemia, bleeding disorders and clotting disorders. The appropriate assessment and treatment plan depends on the individual diagnosis and is discussed with each patient after a review of the relevant findings.
How Dr. Sucak works with international patients
Dr. Sucak consults in Turkish and English, and interpreters can be arranged for other languages. The Acibadem international patient team coordinates the collection of prior reports and imaging, arranges appointments and organizes the hospital visit. A first consultation typically covers the patient’s history and symptoms, a review of existing imaging, laboratory results and previous treatments, a clinical examination and a discussion of the available options. Video consultation is available for international patients who wish to discuss their case before or instead of traveling.
What Dr. Sucak treats and performs
Each item opens the condition or treatment page with the care pathway for international patients.
Conditions treated
- Leukemia
- Lymphoma
- Myeloproliferative diseases
- Multiple myeloma
- Hairy cell leukemia
- Sickle cell disease
- Basal cell carcinoma
- Bleeding disorders
Procedures performed
- Bone marrow transplantation
- Leukemia treatment
- Lymphoma treatment
- Multiple myeloma treatment
- Clotting disorder treatment
- Anemia treatment
- Bone marrow transplant
Education, career and memberships
Education & training
Education
- 1999Gazi University Faculty of Medicine Hematology
- 1993Gazi University Faculty of Medicine Internal Medicine
- 1987Ankara University Faculty of Medicine
Career
Professional Experience
- 2024Acıbadem Healthcare Services
- 2015Bahçelievler- Medicalpark Hospital, Hematology and Bone Marrow Transplantation Unit
- 2008–2015Professor, Gazi University Faculty of Medicine, Department of Hematology
- 2000–2008Associate Professor, Gazi University Faculty of Medicine, Department of Hematology
- 1999–2000Assistant Associate Professor, Gazi University Faculty of Medicine, Department of Hematology
- 1995–1996Ankara Zekai Tahir Burak Training and Research Hospital, Internal Medicine consultant
- 1993–1995Ankara Sevgi Hospital, Internal Medicine Specialist
Selected publications
Selected Publications
- Genetic Evaluation of the Patients with Clinically Diagnosed Inborn Errors of Immunity by Whole Exome Sequencing: Results from a Specialized Research Çenter for Immunodeficiency in Turkey. J Clin Immunoi. 2024 Jul 2;44(7):157. doi: 10.1007/sl0875-024-01759-w.PMID: 38954121 Erman B, Aba U, Ipsir C, Pehlivan D, Aytekin C, Cildir G, Cicek B, Bozkurt C, Tekeoglu S, Kaya M, Aydogmus C, Cipe F, Sucak G, Eltan SB, Özen A, Ba
- Lymphoproliferation, Autoimmunity, and Recurrent Infections: Which Primary Immunodeficiency? Türk Arch Pediatr2023 Sep 22;59(l):106-8. doi: 10.5152/TurkArchPediatr.2023.23157. Online ahead of print. Öztürk G, Flaskoloğlu Ş, Deveci N, Erkmen FI, Çelik NA, Sucak G, Ceylaner S, İkincioğulları A, Doğu F.
- Flematopoietic Stem Celi Transplantation for Patients with Paroxysmal Nocturnal Flemoglobinuria with or without Aplastic Anemia: A Multicenter Turkish Experience Türk J Haematol. 2021 Aug 25;38(3):195-203. doi: 10.4274/tjh.galenos.2021.2021.0105. Epub 2021 May 31. Yılmaz F, Soyer N, Cengiz Seval G, Civriz Bozdağ S, Topcuoğlu P, Ünal A, Kaynar L, Özgür G, Sucak G, Göker FI, Velet M, Özdoğu H, Yılmaz M, Kaya E,
- Role of glutathione S-transferase P1 polymorphism in early transplant complications in patients undergoing allogeneic stem cell transplantation Cancer Res Ther. 2021 Apr- Jun;17(2):565-573. doi: 10.4103/jcrt.JCRT_61_20. Saritas FI, Suyani E, Güntekin S, Zeynep AŞ, Ergün MA, Çelik B, Sucak GT.
- COVID-19 infection in patients with acute leukemia; Istanbul experience Am J Blood Res. 2021 Aug 15;ll(4):427-437. eCollection 2021. Buyuktas D, Acar K, Sucak G, Toptas T, Kapucu I, Bekoz H, Erdem S, Nalcaci M, Atalay F, Akay MO, Ferhanoglu B.
- Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic Rheumatol Int. 2020 Jun 25:1-12. doi: 10.1007/s00296-020-04636-y. Online ahead of print. Soy M, Atagunduz P, Atagunduz I, Sucak GT.
- A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience Türk J Haematol. 2019 Nov 18;36(4):230-237 Çekdemir D, Güvenç S, Özdemirkıran F, Eser A, ToptaşT, Özkocaman V, Flaydaroğlu Şahin FI, Ermiş Turak E, Esen R, Cömert M, Sadri S, Aslaner M, Uncu
- Differences in pulmonary and extra- pulmonary characteristics in severely versus non-severely fatigued recipients of allogeneic hematopoietic stem cell transplantation: a cross-sectional, comparative study Hematology. 2019 Dec;24(l):112-122. doi: 10.1080/10245332.2018.1526441. Epub 2018 Sep 27. Barğı Gl, Bosnak Güçlü MI, Türköz Sucak AG.
- Impairments in dyspnea, exercise capacity, physical activity and quality of life of allogeneic hematopoietic stem celi transplantation survivors compa PhysiotherTheory Pract. 2019 Apr 8:1-12 doi: 10.1007/s00520-015-2825-3. Epub 2015 Jul 2. Bosnak Güçlü M, Bargi G, Sucak GT.
- The Incidence of Tuberculosis Infection in Hematopoietic Stem Cell Transplantation Recipients: A retrospective cohort study from a çenter in Turkey TranspI Infect Dis. 2018 Apr 21:el2912. doi: 10.1111/tid.12912. [Epub ahead of print] Akı ŞZ, Sucak GT, Güzel Tunçcan Ö, Köktürk N, Şenol E.
